Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colistin Nephrotoxicity Prevention with Alpha Lipoic Acid
NCT07668141Phase 3Not yet recruiting
- Sponsor
- Helwan University
- Start
- Jun 2026
- Primary completion
- Jan 2027
- Countries
- 1
01
Overview
A Phase 3 trial of alpha-lipoic acid in colistin-induced nephrotoxicity, sponsored by Helwan University. Planned start Jun 2026; status: not yet recruiting.
02
Drugs
alpha-lipoic acid
03
Conditions
colistin-induced nephrotoxicity
Beyond the preview
Go deeper on NCT07668141.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07668141.